ORPHA:662721
Placenta accreta spectrum disorder
Also known as: AIP · Abnormally invasive placenta · PAI · PAS · Placenta accreta spectrum
Publications
3,458
Trials
66
Interventional, condition-specific
Researchers
1,095
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare disorder related with pregnancy characterized by an abnormally invasive placenta that fails to detach spontanously from the uterine wall during delivery. Placenta that partially or totally attached to uterine wall, risk to cause massive and life-threatening bleeding if forced to remove. diagnosis is essential, however difficult, to reduce maternal and fetal morbidity. Major risk factors are uterine surgery and uterine scar secondary to cesarean delivery.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0005916
- MeSH:D010921
- UMLS:C0032044
- NCIT:C26856
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,458 matched papers (3,358 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
66 matched on ClinicalTrials.gov (15 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
1 associated chemical. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Cocaine · marker/mechanism
Literature
Is anyone studying this?
3,458
3,458 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,458 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
3,358 in the last 10 years · low confidence
Phrase hits: 3,315 · MeSH hits: 238
Who's working on it?
1,095
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Einerson BD10 papers · 2025
Department of Obstetrics and Gynecology (Drs Givens and Einerson), University of Utah Health (UUH), Salt Lake City, Utah, USA.
Papers in Europe PMC - 02Jauniaux E9 papers · 2026
Faculty of Population Health Sciences, EGA Institute for Women's Health, University College London (UCL), London, UK.
Papers in Europe PMC - 03Shamshirsaz AA9 papers · 2026
Department of Obstetrics and Gynecology, Baylor College of Medicine, Texas Children's Fetal Center, Houston, TX 77030, USA.
Papers in Europe PMC - 04Bartels HC7 papers · 2026
Department of UCD Obstetrics and Gynecology, School of Medicine, University College Dublin, National Maternity Hospital, Dublin 2, Ireland.
Papers in Europe PMC - 05Silver RM7 papers · 2025
Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT.
Papers in Europe PMC - 06Afshar Y6 papers · 2026
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Papers in Europe PMC - 07Hobson SR6 papers · 2026
Department of Electrical, Computer and Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada; Institute for Biomedical Engineering, Science and Technology (iBEST) at Toronto Metropolitan University, Canada; Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Obstetrics and Gynaecology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Papers in Europe PMC - 08Matsuzaki S6 papers · 2026
Department of Obstetrics and Gynecology, Osaka General Medical Center, Osaka 558-8558, Japan.
Papers in Europe PMC - 09Munoz JL6 papers · 2026
Department of Obstetrics and Gynecology, Baylor College of Medicine, Texas Children's Fetal Center, Houston, TX 77030, USA.
Papers in Europe PMC - 10Nieto-Calvache AJ6 papers · 2026
Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Clínica de Espectro de Acretismo Placentario, Cra 98 No. 18-49, Cali, 760032, Colombia. albaro.nieto@fvl.org.co.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
66
interventional trials for this specific condition
66 interventional trials matched this specific condition name; 15 currently recruiting in our sample.
Data as of 11 September 2026
66 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.9th percentile).
low confidence · 97.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
66 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04866888·RECRUITING·Placenta Accreta Spectrum Outcome After Uterine Conservation
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT07412925·RECRUITING·Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR
Not reviewed·Conditions: Pregnancy · Placenta Accrete Spectrum · Tourniquets · Apgar Score·Matched via MeSH
- NCT06867874·RECRUITING·Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum
Not reviewed·Conditions: Placenta Previa · Placenta Accreta Spectrum·Matched via name + MeSH
- NCT07520201·RECRUITING·Comparison Between 3 Conservative Surgeries for Placenta Accreta Spectrum
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT07250412·ENROLLING BY INVITATION·The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion
Not reviewed·Conditions: Placenta Accrete Spectrum·Matched via name + MeSH
- NCT06620432·RECRUITING·High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT06957184·NOT YET RECRUITING·A Comparison Between Bladder Dissection Before and After Uterine Incision During Cesarean Section for Placenta Accreta Spectrum: A Randomized Controlled Study
Not reviewed·Conditions: Placenta Accreta·Matched via name + MeSH
- NCT07519993·NOT YET RECRUITING·Conservative Management of Placenta Accreta Spectrum Using Kasr Al-Ainy Technique With or Without Hayman Sutures
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT07025954·RECRUITING·Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta
Not reviewed·Conditions: Placenta Previa · Placenta Accreta Spectrum · Antepartum Bleeding · Emergency Cesarean Section·Matched via name + MeSH
- NCT06717997·NOT YET RECRUITING·The Placental Thickness and Pregnancy Outcomes in Placenta Previa Women
Not reviewed·Conditions: Placenta Accreta·Matched via MeSH
- NCT06575023·NOT YET RECRUITING·Tamponade vs Partial Myometrial Resection of Lower Uterine Segment in Management of Placenta Accreta Spectrum Cases
Not reviewed·Conditions: Placenta Accreta·Matched via name + MeSH
- NCT06483724·NOT YET RECRUITING·Comparison Between Cervical Tourniquet and Uterine Artery Ligation Prior to Segmental Resection Approach
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT06721182·NOT YET RECRUITING·Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT06493968·RECRUITING·Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT06512181·RECRUITING·Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
Observational and natural-history studies
71 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06755047·RECRUITING·3D Placental Volume in Placenta Accreta
Not reviewed·Conditions: Placenta Accreta·Matched via MeSH
- NCT05922397·RECRUITING·Placenta Accreta Spectrum Topographic Classification
Not reviewed·Conditions: Placenta Accreta·Matched via name + MeSH
- NCT07643090·RECRUITING·Diagnostic Trial of a Vision Transformer-Based Ultrasound AI Model for Placenta Accreta Spectrum
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT07283042·RECRUITING·Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum
Not reviewed·Conditions: Placenta Accreta·Matched via name + MeSH
- NCT07406841·NOT YET RECRUITING·Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study
Not reviewed·Conditions: Placenta Accreta Spectrum·Matched via name + MeSH
- NCT06861972·NOT YET RECRUITING·Caesarean Hysterectomy Versus Conservative Management of Placenta Accreta: A Comparative Study
Not reviewed·Conditions: Obstetric Complication·Matched via MeSH
- NCT06351969·NOT YET RECRUITING·Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss in Placenta Accreta
Not reviewed·Conditions: Post Partum Hemorrhage·Matched via MeSH
- NCT06833606·RECRUITING·Diagnosis and Outcomes of Placental Accretism
Not reviewed·Conditions: Placenta Accreta·Matched via MeSH
- NCT07452185·NOT YET RECRUITING·Evaluation of Cervical Invasion and Length in Placenta Accreta Patients
Not reviewed·Conditions: Placenta Accreta Spectrum · Placenta Accreta · Placenta Previa·Matched via name + MeSH
- NCT06761885·NOT YET RECRUITING·Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers
Not reviewed·Conditions: Placenta Accreta / Percreta·Matched via MeSH
- NCT07706062·NOT YET RECRUITING·Total Lower Uterine Segmentectomy With Adjunctive Mechanical Towel Compression for the Surgical Management of Placenta Accreta Spectrum Disorders
Not reviewed·Conditions: Placenta Accreta Management·Matched via name + MeSH
- NCT06712576·NOT YET RECRUITING·Evaluation of Planned Conservative Surgical Management of Placenta Accreta Spectrum in Women's Health Center, Assiut University Hospital
Not reviewed·Conditions: Placenta Accreta·Matched via name + MeSH
- NCT07236710·NOT YET RECRUITING·Observation of Strategies in Placenta Accreta Spectrum Management
Not reviewed·Conditions: Placenta Accreta Management·Matched via name + MeSH
- NCT07236060·NOT YET RECRUITING·Ultrasound Model to Help Differentiate Between Placenta Accreta Spectrum and Uterine Dehiscence in 3rd Trimester Pregnancies
Not reviewed·Conditions: Placenta Accreta, Third Trimester · Uterine Scar Dehiscence·Matched via name + MeSH
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 7 · after dedupe 7 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 7 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (7)
- ctis·2024-513600-33-00·Authorised, ongoing·Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10438779·Recruiting·Sleep aids to reduce pre-caesarean anxiety
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15774307·No longer recruiting·Standardisation, acceptability and outcomes of elective (planned) caesarean births where the baby's head is delivered first, and the baby is not fully delivered until after they have taken their first cry or 2 minutes have passed (whichever is sooner)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN39133303·No longer recruiting·Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17814519·No longer recruiting·Tranexamic acid to reduce blood loss at unplanned caesarean delivery
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN94395913·No longer recruiting·Free intake of water compared to carbohydrate beverage up to patient despatch from the ward to the operating theatre for planned Caesarean section
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15821791·No longer recruiting·Self bladder emptying compared to insertion of indwelling catheter, to empty the bladder for caesarean section
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Placenta accreta spectrum disorder — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Placenta accreta spectrum disorder" OR "Abnormally invasive placenta" OR "Placenta accreta spectrum"
MeSH descriptor terms unioned into the query: Placenta Accreta
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Placenta accreta spectrum disorder" OR "Abnormally invasive placenta" OR "Placenta accreta spectrum" OR "Placenta Accreta"
Interventional trials matched via: both, phrase, mesh (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 66 interventional · 71 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: AIP; PAI; PAS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 3 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (3458) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T20:13:13.527Z
